Abstract
Background
Prolonged systemic non-steroidal anti-inflammatory drugs (NSAIDs) have been associated with adverse renal outcomes among older adults. However, there is scant data regarding the renal safety of topical and short-course systemic NSAIDs. We aimed to evaluate the risk of acute adverse renal outcomes among older adults prescribed topical and short-term systemic NSAIDs.
Methods
We conducted a retrospective cohort study of all older adults, age 60 years and above, who received prescriptions between July 2015 and December 2017 from the largest tertiary hospital and a major public primary care institution in Singapore. Data from 6 months before until 30 days after the first prescription were retrieved from electronic medical records. The primary outcome was the incidence of acute kidney injury (serum creatinine increased >26.5 µmol/L or >50% from baseline) and/or hyperkalemia within 30 days. A multi-variate analysis taking into account age, sex, co-morbidities, baseline-estimated glomerular filtration rate and serum potassium, NSAID route of administration, and concurrent renin-angiotensin-aldosterone system blocker and diuretic prescription was performed to evaluate factors associated with the primary outcome.
Results
We identified 12,773 older adults with incident prescriptions: 3982 (31.2%) received short-course systemic NSAIDs, 3784 (29.6%) received topical NSAIDs, and 5007 (39.2%) did not receive any NSAID. Both short-course systemic NSAIDs (adjusted odds ratio [OR] 1.59, 95% confidence interval [CI] 1.41–1.80, p < 0.001) and topical NSAIDs (adjusted OR 1.48, 95% CI 1.31–1.67, p < 0.001), compared with the no-NSAID group, were independently associated with the primary outcome. Among older adults with co-morbid conditions and prescribed NSAIDs, topical NSAIDs had a reduced odds of 30-day incident acute kidney injury and/or hyperkalemia in diabetes mellitus (adjusted OR 0.78, 95% CI 0.65–1.06, p = 0.007), chronic kidney disease (adjusted OR 0.74, 95% CI 0.60–0.90, p = 0.003), and cardiovascular disease (adjusted OR 0.54, 95% CI 0.37–0.79, p < 0.001), compared with short-course systemic NSAIDs.
Conclusions
NSAIDs increased the risk of acute adverse renal events. Topical NSAIDs, compared with short-course systemic NSAIDs, were associated with a reduced incidence of acute kidney injury and/or hyperkalemia among older adults with additional risk factors.
Similar content being viewed by others
References
Zhang X, Donnan PT, Bell S, Guthrie B. Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol. 2017;18(1):256.
Nash DM, Markle-Reid M, Brimble KS, McArthur E, Roshanov PS, Fink JC, et al. Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study. Nephrol Dial Transplant. 2019;4(7):1145–54.
2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–94.
Szeto C-C, Sugano K, Wang J-G, Fujimoto K, Whittle S, Modi GK, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut. 2020;69(4):617–29.
Juhlin T, Björkman S, Höglund P. Cyclooxygenase inhibition causes marked impairment of renal function in elderly subjects treated with diuretics and ACE-inhibitors. Eur J Heart Fail. 2005;7(6):1049–56.
Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med. 2000;160(6):777–84.
Bally M, Beauchamp ME, Abrahamowicz M, Nadeau L, Brophy JM. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiol Drug Saf. 2018;27(1):69–77.
Altman RD. New guidelines for topical NSAIDs in the osteoarthritis treatment paradigm. Curr Med Res Opin. 2010;26(12):2871–6.
Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases. Drugs. 2000;60(3):555–74.
Zeng C, Wei J, Persson MS, Sarmanova A, Doherty M, Xie D, et al. Relative efficacy and safety of topical non-steroidal anti-inflammatory drugs for osteoarthritis: a systematic review and network meta-analysis of randomised controlled trials and observational studies. Br J Sports Med. 2018;52(10):642–50.
Fernando AH, Thomas S, Temple RM, Lee HA. Renal failure after topical use of NSAIDs. BMJ. 1994;308(6927):533.
Andrews PA, Sampson SA. Topical non-steroidal drugs are systemically absorbed and may cause renal disease. Nephrol Dial Transplant. 1999;14(1):187–9.
Nishtala PS, Chyou TY. Identifying drug combinations associated with acute kidney injury using association rules method. Pharmacoepidemiol Drug Saf. 2020;29(4):467–73.
Chi T-Y, Zhu H-M, Zhang M. Risk factors associated with nonsteroidal anti-inflammatory drugs (NSAIDs)-induced gastrointestinal bleeding resulting on people over 60 years old in Beijing. Medicine (Baltimore). 2018;97(18):e0665.
Harvey JA, Chastin SF, Skelton DA. Prevalence of sedentary behavior in older adults: a systematic review. Int J Environ Res Public Health. 2013;10(12):6645–61.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Annal Intern Med. 2009;150(9):604–12.
Dreischulte T, Morales DR, Bell S, Guthrie B. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin–angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney Int. 2015;88(2):396–403.
Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2(1):1–138.
Schneider V, Lévesque LE, Zhang B, Hutchinson T, Brophy JM. Association of selective and conventional nonsteroidal antinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol. 2006;164(9):881–9.
Griffin MR, Yared A, Ray WA. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol. 2000;151(5):488–96.
Horl WH. Nonsteroidal anti-inflammatory drugs and the kidney. Pharmaceuticals. 2010;3(7):2291–321.
Chou C-I, Shih C-J, Chen Y-T, Ou S-M, Yang C-Y, Kuo S-C, et al. Adverse effects of oral nonselective and cyclooxygenase-2-selective NSAIDs on hospitalization for acute kidney injury: a nested case–control cohort study. Medicine (Baltimore). 2016;95(9):e2645.
Solomon DH, Husni ME, Wolski KE, Wisniewski LM, Borer JS, Graham DY, et al. Differences in safety of nonsteroidal antiinflammatory drugs in patients with osteoarthritis and patients with rheumatoid arthritis: a randomized clinical trial. Arthritis Rheumatol. 2018;70(4):537–46.
Kate RJ, Perez RM, Mazumdar D, Pasupathy KS, Nilakantan V. Prediction and detection models for acute kidney injury in hospitalized older adults. BMC Med Inform Decis Mak. 2016;16(1):39.
Evans J, McGregor E, McMahon AD, McGilchrist MM, Jones MC, White G, et al. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM. 1995;88(8):551–7.
Lin TC, Solomon DH, Tedeschi SK, Yoshida K, Kao Yang YH. Comparative risk of cardiovascular outcomes between topical and oral nonselective NSAIDs in Taiwanese patients with rheumatoid arthritis. J Am Heart Assoc. 2017;6(11):e006874.
Makris UE, Kohler MJ, Fraenkel L. Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review. J Rheumatol. 2010;37(6):1236–43.
Pham PC, Khaing K, Sievers TM, Pham PM, Miller JM, Pham SV, et al. 2017 update on pain management in patients with chronic kidney disease. Clin Kidney J. 2017;10(5):688–97.
Persons O. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc. 2009;57(8):1331–46.
Davison SN, Rathwell S, George C, Hussain ST, Grundy K, Dennett L. Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis. Can J Kidney Health Dis. 2020;7:2054358120910329.
Zhan M, Doerfler RM, Xie D, Chen J, Chen H-Y, Diamantidis CJ, et al. Association of opioids and nonsteroidal anti-inflammatory drugs with outcomes in CKD: findings from the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis. 2020;76(2):184–93.
Pickering G, Marcoux M, Chapiro S, David L, Rat P, Michel M, et al. An algorithm for neuropathic pain management in older people. Drugs Aging. 2016;33(8):575–83.
Modig S, Elmståhl S. Kidney function and use of nonsteroidal anti-inflammatory drugs among elderly people: a cross-sectional study on potential hazards for an at risk population. Int J Clin Pharm. 2018;40(4):870–7.
Pilotto A, Franceschi M, Leandro G, Di Mario F. NSAID and aspirin use by the elderly in general practice. Drugs Aging. 2003;20(9):701–10.
Acknowledgements
We thank the SingHealth Health Services Research Center, the SingHealth Research Office, the Research Efficiency Enhancement Program, and the SingHealth Polyclinics Department of Research Administration for administrative support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This research was supported by the SHF-Foundation Research Grant (SHF/HSRHO014/2017).
Conflicts of interest
Cynthia Ciwei Lim, Andrew Teck Wee Ang, Hanis Bte Abdul Kadir, Puay Hoon Lee, Bandy Qiuling Goh, Sudha Harikrishnan, Jia Liang Kwek, Sheryl S.W. Gan, Jason Chon Jun Choo, and Ngiap Chuan Tan have no conflicts of interest that are directly relevant to the content of this article.
Ethics approval
This study was conducted according to the Declaration of Helsinki. Waiver of informed consent for use of de-identified electronic medical record data was approved by the local institutional review board (2018/2567).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Availability of data and material
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
Authors’ contributions
CCL, ATWA, TNC, PHL, BQG, KJL, and JC contributed to the study conception and design. Material preparation, data collection, and analysis were performed by CCL, HBAK, and SH. The first draft of the manuscript was written by CCL. All authors read and approved the final manuscript.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lim, C.C., Ang, A.T.W., Kadir, H.B.A. et al. Short-Course Systemic and Topical Non-Steroidal Anti-Inflammatory Drugs: Impact on Adverse Renal Events in Older Adults with Co-Morbid Disease. Drugs Aging 38, 147–156 (2021). https://doi.org/10.1007/s40266-020-00824-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40266-020-00824-4